Instil Bio Inc has a consensus price target of $14.17 based on the ratings of 7 analysts. The high is $32 issued by Baird on May 13, 2024. The low is $2 issued by Morgan Stanley on December 12, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Baird, and Jefferies on May 13, 2024, May 13, 2024, and April 12, 2024, respectively. With an average price target of $20.33 between HC Wainwright & Co., Baird, and Jefferies, there's an implied 63.32% upside for Instil Bio Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/13/2024 | Buy Now | 44.58% | HC Wainwright & Co. | Mitchell Kapoor | → $18 | Reiterates | Buy → Buy | Get Alert |
05/13/2024 | Buy Now | 157.03% | Baird | Jack Allen | $54 → $32 | Maintains | Outperform | Get Alert |
04/12/2024 | Buy Now | -11.65% | Jefferies | Kelly Shi | $5 → $11 | Downgrade | Buy → Hold | Get Alert |
03/25/2024 | Buy Now | 44.58% | HC Wainwright & Co. | Mitchell Kapoor | → $18 | Reiterates | Buy → Buy | Get Alert |
01/22/2024 | Buy Now | 44.58% | HC Wainwright & Co. | Mitchell Kapoor | $2 → $18 | Maintains | Buy | Get Alert |
01/19/2024 | Buy Now | 333.73% | Baird | Jack Allen | → $54 | Reiterates | Outperform → Outperform | Get Alert |
01/17/2024 | Buy Now | 333.73% | Baird | Jack Allen | $100 → $54 | Maintains | Outperform | Get Alert |
11/14/2023 | Buy Now | -83.94% | HC Wainwright & Co. | Mitchell Kapoor | → $40 | Reiterates | Buy → Buy | Get Alert |
08/17/2023 | Buy Now | -83.94% | HC Wainwright & Co. | Mitchell Kapoor | → $40 | Reiterates | Buy → Buy | Get Alert |
06/29/2023 | Buy Now | -83.94% | HC Wainwright & Co. | Mitchell Kapoor | → $40 | Initiates | → Buy | Get Alert |
04/05/2023 | Buy Now | -51.81% | Truist Securities | Asthika Goonewardene | → $120 | Reinstates | → Hold | Get Alert |
12/12/2022 | Buy Now | -83.94% | Morgan Stanley | Vikram Purohit | $120 → $40 | Maintains | Equal-Weight | Get Alert |
11/17/2022 | Buy Now | 12.45% | Baird | Jack Allen | $480 → $280 | Maintains | Outperform | Get Alert |
11/01/2022 | Buy Now | -51.81% | Morgan Stanley | Vikram Purohit | $160 → $120 | Maintains | Equal-Weight | Get Alert |
11/01/2022 | Buy Now | 92.77% | Baird | Jack Allen | $620 → $480 | Maintains | Outperform | Get Alert |
11/01/2022 | Buy Now | — | Cowen & Co. | Yaron Werber | — | Downgrade | Outperform → Market Perform | Get Alert |
09/06/2022 | Buy Now | 149% | Baird | Jack Allen | $680 → $620 | Maintains | Outperform | Get Alert |
08/24/2022 | Buy Now | -35.74% | Morgan Stanley | Vikram Purohit | $180 → $160 | Maintains | Equal-Weight | Get Alert |
08/23/2022 | Buy Now | 28.51% | Truist Securities | Robyn Karnauskas | $500 → $320 | Maintains | Buy | Get Alert |
06/06/2022 | Buy Now | -27.71% | Morgan Stanley | Vikram Purohit | $280 → $180 | Maintains | Equal-Weight | Get Alert |
05/24/2022 | Buy Now | 12.45% | Morgan Stanley | Vikram Purohit | $300 → $280 | Maintains | Equal-Weight | Get Alert |
08/13/2021 | Buy Now | 173.09% | Baird | Jack Allen | → $680 | Initiates | → Outperform | Get Alert |
The latest price target for Instil Bio (NASDAQ:TIL) was reported by HC Wainwright & Co. on May 13, 2024. The analyst firm set a price target for $18.00 expecting TIL to rise to within 12 months (a possible 44.58% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Instil Bio (NASDAQ:TIL) was provided by HC Wainwright & Co., and Instil Bio reiterated their buy rating.
There is no last upgrade for Instil Bio
The last downgrade for Instil Bio Inc happened on April 12, 2024 when Jefferies changed their price target from $5 to $11 for Instil Bio Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Instil Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Instil Bio was filed on May 13, 2024 so you should expect the next rating to be made available sometime around May 13, 2025.
While ratings are subjective and will change, the latest Instil Bio (TIL) rating was a reiterated with a price target of $18.00 to $18.00. The current price Instil Bio (TIL) is trading at is $12.45, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.